A detailed history of Driehaus Capital Management LLC transactions in Incyte Corp stock. As of the latest transaction made, Driehaus Capital Management LLC holds 111,919 shares of INCY stock, worth $8.12 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
111,919
Previous 112,354 0.39%
Holding current value
$8.12 Million
Previous $6.81 Million 8.62%
% of portfolio
0.07%
Previous 0.07%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$57.33 - $68.61 $24,938 - $29,845
-435 Reduced 0.39%
111,919 $7.4 Million
Q2 2024

Aug 14, 2024

SELL
$51.18 - $63.75 $2.94 Million - $3.67 Million
-57,491 Reduced 33.85%
112,354 $6.81 Million
Q1 2024

May 15, 2024

SELL
$56.55 - $66.59 $261,204 - $307,579
-4,619 Reduced 2.65%
169,845 $9.68 Million
Q4 2023

Feb 14, 2024

BUY
$52.16 - $64.19 $9.1 Million - $11.2 Million
174,464 New
174,464 $11 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.1B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Driehaus Capital Management LLC Portfolio

Follow Driehaus Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Driehaus Capital Management LLC with notifications on news.